Core Viewpoint - Ma Yinglong reported a revenue of 2.837 billion yuan for the first three quarters of 2025, reflecting a year-on-year increase of 1.63%, and a net profit attributable to shareholders of 501 million yuan, up 9.51% year-on-year [1] Financial Performance - For the third quarter, the company achieved a revenue of 888 million yuan, which is a 2.8% increase year-on-year [1] - The net profit attributable to shareholders for the third quarter was 158 million yuan, representing an 8.38% year-on-year increase [1] - The non-recurring net profit attributable to shareholders for the third quarter was 146 million yuan, showing a year-on-year increase of 4.32% [1] Business Focus and Strategy - The company continues to focus on the anorectal field, establishing itself as a leading brand in this niche market [1] - Leveraging its brand influence and structural advantages in the anorectal sector, the company is actively expanding into medical services and the health industry [1] - Ma Yinglong has established over 60 directly operated specialty hospitals and co-built anorectal diagnosis and treatment centers [1] - The health products offered by the company include four categories: functional skincare products, functional nursing products, functional foods, and anorectal health products [1]